Published in J Psychiatr Pract on September 01, 2005
Cigarette smoking and mortality risk in people with schizophrenia. Schizophr Bull (2009) 1.95
A systematic review of the international published literature relating to quality of institutional care for people with longer term mental health problems. BMC Psychiatry (2009) 1.36
Advisor-Teller Money Manager (ATM) therapy for substance use disorders. Psychiatr Serv (2010) 1.30
The catatonic dilemma expanded. Ann Gen Psychiatry (2006) 1.18
Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome. Physiol Behav (2007) 1.13
Beyond the limitations of best practices: how logic analysis helped reinterpret dual diagnosis guidelines. Eval Program Plann (2006) 1.10
Development of a family-based program to reduce risk and promote resilience among families affected by maternal depression: theoretical basis and program description. Clin Child Fam Psychol Rev (2008) 1.09
Substance abuse and schizophrenia: pharmacotherapeutic intervention. J Subst Abuse Treat (2007) 1.03
Integrating services for patients with mental and substance use disorders: What matters? Health Care Manage Rev (2010) 0.97
Intrinsic motivation as a mediator of relationships between symptoms and functioning among individuals with schizophrenia spectrum disorders in a diverse urban community. J Nerv Ment Dis (2010) 0.90
Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep (2012) 0.89
A brief treatment engagement intervention for individuals with co-occurring mental illness and substance use disorders: results of a randomized clinical trial. Community Ment Health J (2010) 0.87
Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services. Clin Pract Epidemiol Ment Health (2008) 0.85
Cigarette Smoking and Health Characteristics in Individuals With Serious Mental Illness Enrolled in a Behavioral Weight Loss Trial. J Dual Diagn (2013) 0.85
A cluster randomized Hybrid Type III trial testing an implementation support strategy to facilitate the use of an evidence-based practice in VA homeless programs. Implement Sci (2015) 0.79
Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia. J Dual Diagn (2007) 0.79
Adapting Motivational Interventions for Comorbid Schizophrenia and Alcohol Use Disorders. Clin Psychol (New York) (2007) 0.79
Physical Health and Dual Diagnosis. Adv Dual Diagn (2008) 0.78
Free-running rhythms of cocaine self-administration in rats held under constant lighting conditions. Chronobiol Int (2010) 0.78
Evolution of Substance use, Neurological and Psychiatric Symptoms in Schizophrenia and Substance use Disorder Patients: A 12-Week, Pilot, Case-Control Trial with Quetiapine. Front Psychiatry (2011) 0.77
The impact of substance abuse on osteoporosis screening and risk of osteoporosis in women with psychotic disorders. Osteoporos Int (2010) 0.77
A roadmap to key pharmacologic principles in using antipsychotics. Prim Care Companion J Clin Psychiatry (2007) 0.77
Implementing Residential Integrated Treatment for Co-occurring Disorders. J Dual Diagn (2013) 0.77
Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis. J Dual Diagn (2014) 0.76
The efficacy of assertive community treatment to treat substance use. J Am Psychiatr Nurses Assoc (2011) 0.75
A Hybrid III stepped wedge cluster randomized trial testing an implementation strategy to facilitate the use of an evidence-based practice in VA Homeless Primary Care Treatment Programs. Implement Sci (2017) 0.75
Professionals' perception on the management of patients with dual disorders. Patient Prefer Adherence (2016) 0.75
Jail-to-community treatment continuum for adults with co-occurring substance use and mental disorders: study protocol for a pilot randomized controlled trial. Trials (2017) 0.75
Naltrexone efficacy in treating alcohol-use disorder in individuals with comorbid psychosis: a systematic review. Ther Adv Psychopharmacol (2017) 0.75
Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. Addiction (1993) 41.55
In search of how people change. Applications to addictive behaviors. Am Psychol (1992) 28.48
Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA (1990) 17.70
The drug abuse screening test. Addict Behav (1982) 9.55
Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry (2004) 6.40
Reliability of alcohol use indices. The Lifetime Drinking History and the MAST. J Stud Alcohol (1982) 4.36
Physical health monitoring of patients with schizophrenia. Am J Psychiatry (2004) 3.54
Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Public Health (2001) 3.46
Are mood disorders and obesity related? A review for the mental health professional. J Clin Psychiatry (2004) 3.26
Implementing dual diagnosis services for clients with severe mental illness. Psychiatr Serv (2001) 3.16
Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry (1995) 2.73
Drug interactions with tobacco smoking. An update. Clin Pharmacokinet (1999) 2.52
Models of community care for severe mental illness: a review of research on case management. Schizophr Bull (1998) 2.49
Addressing tobacco among individuals with a mental illness or an addiction. Addict Behav (2004) 2.48
Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry (2001) 2.23
The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary. J Clin Psychiatry (2003) 2.15
A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biol Psychiatry (2002) 1.86
Risk factors for homelessness among schizophrenic men: a case-control study. Am J Public Health (1994) 1.83
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry (2000) 1.82
Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry (2001) 1.81
Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis (2003) 1.80
Substance use reduction in the context of outpatient psychiatric treatment: a collaborative, motivational, harm reduction approach. Community Ment Health J (1996) 1.76
The effects of clinical case management on hospital service use among ED frequent users. Am J Emerg Med (2000) 1.75
The distribution of body mass index among individuals with and without schizophrenia. J Clin Psychiatry (1999) 1.67
Substance abuse among patients with treatment-resistant schizophrenia: characteristics and implications for clozapine therapy. Am J Psychiatry (1994) 1.64
Substance abuse in schizophrenia: service utilization and costs. J Nerv Ment Dis (1993) 1.55
Risk for cancer in parents of patients with schizophrenia. Am J Psychiatry (2004) 1.54
The role of laboratory tests in alcoholism treatment. J Subst Abuse Treat (2001) 1.53
The association of medical comorbidity in schizophrenia with poor physical and mental health. J Nerv Ment Dis (1999) 1.50
Dartmouth Assessment of Lifestyle Instrument (DALI): a substance use disorder screen for people with severe mental illness. Am J Psychiatry (1998) 1.48
The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia. Schizophr Bull (2000) 1.47
Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone--a multiple-dose study. Biol Psychiatry (1998) 1.40
The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update. J Clin Psychiatry (2004) 1.35
Nicotine dependence and schizophrenia. Hosp Community Psychiatry (1994) 1.32
Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective. CNS Drugs (2001) 1.31
Hepatitis B virus infection and vaccination among young injection and non-injection drug users: missed opportunities to prevent infection. Drug Alcohol Depend (2004) 1.28
Comorbidity of schizophrenia and substance abuse: implications for treatment. J Consult Clin Psychol (1992) 1.25
Cannabis affects the severity of schizophrenic symptoms: results of a clinical survey. Psychol Med (1986) 1.25
A pilot trial of bupropion added to cognitive behavioral therapy for smoking cessation in schizophrenia. Nicotine Tob Res (2001) 1.23
Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophr Bull (1997) 1.21
Medication compliance among patients with bipolar disorder and substance use disorder. J Clin Psychiatry (1998) 1.20
Motivation to quit using substances among individuals with schizophrenia: implications for a motivation-based treatment model. Schizophr Bull (1997) 1.17
Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther (1995) 1.12
Alcoholics Anonymous and the use of medications to prevent relapse: an anonymous survey of member attitudes. J Stud Alcohol (2000) 1.11
An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. J Addict Dis (1995) 1.08
Smoking and vulnerability for schizophrenia. Schizophr Bull (1996) 1.08
Severe mental illness and addictions: assessment considerations. Addict Behav (1999) 1.07
Dual diagnosis: HIV and mental illness, a population-based study. Community Ment Health J (2001) 1.06
Patterns of substance abuse in schizophrenia: nature and significance. J Psychiatr Res (1994) 1.04
Treating substance abuse among patients with schizophrenia. Psychiatr Serv (1999) 1.03
Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey. J Clin Psychopharmacol (2000) 1.02
An analysis of cue reactivity among persons with and without schizophrenia who are addicted to cocaine. Psychiatr Serv (2002) 1.02
Alcohol and cannabis use in schizophrenia: effects of clozapine vs. risperidone. Schizophr Res (2003) 1.02
Integrated treatment of co-occurring mental illness and addiction: clinical intervention, program, and system perspectives. CNS Spectr (2004) 1.01
Effects of sustained-release bupropion and supportive group therapy on cigarette consumption in patients with schizophrenia. Am J Psychiatry (2001) 1.00
Comorbidity: cannabis and complexity. J Psychiatr Pract (2005) 0.99
A longitudinal study of substance use and community violence in schizophrenia. J Nerv Ment Dis (1994) 0.98
Naltrexone augmentation of neuroleptic treatment in alcohol abusing patients with schizophrenia. Psychopharmacology (Berl) (2003) 0.98
Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence. Can J Psychiatry (2002) 0.95
Modified therapeutic community for mentally ill chemical "abusers": background; influences; program description; preliminary findings. Subst Use Misuse (1997) 0.93
Olanzapine treatment for patients with schizophrenia and substance abuse. J Subst Abuse Treat (2001) 0.93
Gender differences in hepatitis C infection and risks among persons with severe mental illness. Psychiatr Serv (2003) 0.92
Determinants of smoking behaviour in outpatients with schizophrenia. Schizophr Res (2000) 0.90
Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord (2002) 0.89
Treating substance abuse in schizophrenia. An initial report. J Subst Abuse Treat (2001) 0.89
Time-limited assertive community treatment for homeless persons with severe mental illness. Arch Gen Psychiatry (2001) 0.89
Use of antipsychotic medications among HIV-infected individuals with schizophrenia. Schizophr Res (2004) 0.88
Psychopathology in dual diagnosis and non-addicted schizophrenics--are there differences? Eur Arch Psychiatry Clin Neurosci (2001) 0.88
Drug abuse, psychiatric disorders, and AIDS. Dual and triple diagnosis. West J Med (1990) 0.88
Clozapine and substance abuse in patients with schizophrenia. Can J Psychiatry (1998) 0.87
Characteristics and treatment of homeless, mentally ill, chemical-abusing men. J Psychoactive Drugs (1995) 0.86
Alcohol consumption and abnormalities of brain structure and vasculature. Am J Geriatr Cardiol (2004) 0.84
Decreased substance use in chronically psychotic patients treated with clozapine. Am J Psychiatry (1994) 0.84
Emergency room outreach to chronically addicted individuals. A pilot study. J Subst Abuse Treat (2000) 0.83
Psychopharmacotherapy of psychiatric syndromes in asymptomatic and symptomatic HIV infection. Psychiatr Med (1991) 0.83
Reduction of comorbid substance abuse with clozapine. Am J Psychiatry (1995) 0.82
A case series of nicotine nasal spray in the treatment of tobacco dependence among patients with schizophrenia. Psychiatr Serv (2004) 0.82
Novel antipsychotic medications and the treatment of comorbid substance abuse in schizophrenia. J Subst Abuse Treat (1998) 0.81
Executive and motor skill functioning among cocaine-dependent schizophrenics and non-drug-abusing schizophrenics. J Nerv Ment Dis (2002) 0.81
Feasibility of a skills training approach to reduce substance dependence among individuals with schizophrenia. Psychiatr Serv (2003) 0.81
Olanzapine response in treatment-refractory schizophrenic patients with a history of substance abuse. Schizophr Res (1998) 0.81
The dually diagnosed patient with psychotic symptoms. J Addict Dis (1993) 0.80
Alcohol consumption and cardiovascular risk factors. Recent Dev Alcohol (1985) 0.79
Smoking impact on CYP1A2 activity in a group of patients with schizophrenia. Eur Neuropsychopharmacol (2004) 0.79
Clinical effects of recent cocaine use on patients with acute schizophrenia. Am J Psychiatry (1995) 0.79
Significant interaction between clozapine and cocaine in cocaine addicts. Drug Alcohol Depend (2000) 0.79
Clozapine for substance-abusing schizophrenic patients. Am J Psychiatry (1999) 0.79
Flupenthixol treatment for cocaine abusers with schizophrenia: a pilot study. Am J Drug Alcohol Abuse (1998) 0.78
A pilot double blind placebo controlled trial of sertraline with naltrexone in the treatment of opiate dependence. Am J Addict (2002) 0.78
Outpatient treatment of adults with coexisting substance use and mental disorders. J Subst Abuse Treat (1990) 0.78
A comparison of experts' perspectives on assertive community treatment and intensive case management. Psychiatr Serv (2002) 0.78
Chronic mentally ill individuals reentering the community after hospitalization. Phase II: The urban experience. J Psychiatr Ment Health Nurs (1999) 0.78
Can risperidone reduce cocaine use in substance abusing schizophrenic patients? J Clin Psychopharmacol (2002) 0.77
Serving the dually diagnosed homeless: program development and interventions. J Ment Health Adm (1993) 0.76
Alcohol & drug abuse: a preliminary investigation of cocaine craving among persons with and without schizophrenia. Psychiatr Serv (2001) 0.76
A pilot assessment at one month of 17 dual diagnosis patients. Hosp Community Psychiatry (1990) 0.76
A pilot study of residential treatment for dual diagnoses. J Nerv Ment Dis (1996) 0.76
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA (2006) 13.15
Hyperactivity and hyperconnectivity of the default network in schizophrenia and in first-degree relatives of persons with schizophrenia. Proc Natl Acad Sci U S A (2009) 6.09
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial. JAMA (2003) 5.19
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial. JAMA (2010) 3.94
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry (2003) 3.85
Antipsychotic drug effects on brain morphology in first-episode psychosis. Arch Gen Psychiatry (2005) 3.78
Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv (2002) 3.15
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry (2003) 2.43
Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Am J Psychiatry (2009) 2.39
Acceptability of drug testing in an outpatient substance abuse program for adolescents. J Adolesc Health (2010) 2.12
Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations. Arch Gen Psychiatry (2009) 1.97
The relationship between smoking and suicidal behavior, comorbidity, and course of illness in bipolar disorder. J Clin Psychiatry (2006) 1.93
Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend (2006) 1.92
Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendations. Pain (2013) 1.89
Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry (2010) 1.81
Pharmacological approaches to methamphetamine dependence: a focused review. Br J Clin Pharmacol (2010) 1.71
Course and predictors of weight gain in people with first-episode psychosis treated with olanzapine or haloperidol. Br J Psychiatry (2005) 1.68
Addressing tobacco use disorder in smokers in early remission from alcohol dependence: the case for integrating smoking cessation services in substance use disorder treatment programs. Clin Psychol Rev (2010) 1.67
Genomewide linkage disequilibrium mapping of severe bipolar disorder in a population isolate. Am J Hum Genet (2002) 1.62
Genomewide suggestive linkage of opioid dependence to chromosome 14q. Hum Mol Genet (2007) 1.54
A randomized trial of 6-month methadone maintenance with standard or minimal counseling versus 21-day methadone detoxification. Drug Alcohol Depend (2008) 1.54
Physical pain and associated clinical characteristics in treatment-seeking patients in four substance use disorder treatment modalities. Am J Addict (2008) 1.52
Using a pharmacy-based intervention to improve antipsychotic adherence among patients with serious mental illness. Schizophr Bull (2009) 1.51
Initial response as a predictor of 12-week buprenorphine-naloxone treatment response in a prescription opioid-dependent population. J Clin Psychiatry (2015) 1.51
Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode. Schizophr Res (2005) 1.48
A double-blind, placebo-controlled trial assessing the efficacy of varenicline tartrate for alcohol dependence. J Addict Med (2013) 1.47
A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J Stud Alcohol Suppl (2005) 1.47
Wireless Technologies, Ubiquitous Computing and Mobile Health: Application to Drug Abuse Treatment and Compliance with HIV Therapies. J Med Toxicol (2010) 1.40
Preliminary efforts directed toward the detection of craving of illicit substances: the iHeal project. J Med Toxicol (2012) 1.39
Seeking safety therapy for adolescent girls with PTSD and substance use disorder: a randomized controlled trial. J Behav Health Serv Res (2006) 1.39
Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study. Drug Alcohol Depend (2013) 1.33
Assessing negative consequences in patients with substance use and bipolar disorders: psychometric properties of the short inventory of problems (SIP). Am J Addict (2007) 1.33
Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend (2004) 1.30
The validity of cocaine dependence subtypes. Addict Behav (2007) 1.28
Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers. Mol Med (2008) 1.27
Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders. Addict Behav (2009) 1.27
Does report of craving opioid medication predict aberrant drug behavior among chronic pain patients? Clin J Pain (2009) 1.27
Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr Res (2006) 1.24
Seeking Safety plus Exposure Therapy: an outcome study on dual diagnosis men. J Psychoactive Drugs (2005) 1.24
HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse. Drug Alcohol Depend (2007) 1.23
Serious mental illness and tobacco addiction: a model program to address this common but neglected issue. Am J Med Sci (2003) 1.20
The longitudinal relationship between drug use and risky sexual behaviors among colombian adolescents. Arch Pediatr Adolesc Med (2002) 1.20
Clinical factors associated with prescription drug use disorder in urban primary care patients with chronic pain. J Pain (2010) 1.19
Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Am J Psychiatry (2007) 1.14
Past anabolic-androgenic steroid use among men admitted for substance abuse treatment: an underrecognized problem? J Clin Psychiatry (2003) 1.11
Medical service use and financial charges among opioid users at a public hospital. Drug Alcohol Depend (2002) 1.10
Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat (2013) 1.08
Addressing substance abuse in health care settings. Alcohol Clin Exp Res (2006) 1.08
A double-blind, placebo-controlled trial to assess the efficacy of quetiapine fumarate XR in very heavy-drinking alcohol-dependent patients. Alcohol Clin Exp Res (2011) 1.08
The neural circuitry of reward and its relevance to psychiatric disorders. Curr Psychiatry Rep (2004) 1.07
A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders. Addict Behav (2009) 1.07
Domestic violence in women with PTSD and substance abuse. Addict Behav (2004) 1.07
Clozapine use and relapses of substance use disorder among patients with co-occurring schizophrenia and substance use disorders. Schizophr Bull (2006) 1.07
Correlates of co-occurring ADHD in drug-dependent subjects: prevalence and features of substance dependence and psychiatric disorders. Addict Behav (2008) 1.06
Enhancing validity in co-occurring disorders treatment research. Schizophr Bull (2006) 1.06
A double-blind, placebo-controlled trial assessing the efficacy of levetiracetam extended-release in very heavy drinking alcohol-dependent patients. Alcohol Clin Exp Res (2012) 1.05
Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals. Drug Alcohol Depend (2008) 1.04
Association of variants in MANEA with cocaine-related behaviors. Arch Gen Psychiatry (2009) 1.03
Dense genomewide linkage scan for alcohol dependence in African Americans: significant linkage on chromosome 10. Biol Psychiatry (2008) 1.03
History of abuse and drinking outcomes following inpatient alcohol treatment: a prospective study. Drug Alcohol Depend (2002) 1.03
An intervention for treating alcohol dependence: relating elements of Medical Management to patient outcomes with implications for primary care. Ann Fam Med (2008) 1.03
Substance dependence low-density whole genome association study in two distinct American populations. Hum Genet (2008) 1.03
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD. J Clin Psychopharmacol (2004) 1.01
A randomized trial of transcutaneous electric acupoint stimulation as adjunctive treatment for opioid detoxification. J Subst Abuse Treat (2009) 1.01
Relationship between medication adherence and treatment outcomes: the COMBINE study. Alcohol Clin Exp Res (2008) 1.01
The Short Inventory of Problems - revised (SIP-R): psychometric properties within a large, diverse sample of substance use disorder treatment seekers. Psychol Addict Behav (2012) 1.01
HIV risk behavior in opioid dependent adults seeking detoxification treatment: an exploratory comparison of heroin and oxycodone users. Am J Addict (2009) 1.01
Real-time mobile detection of drug use with wearable biosensors: a pilot study. J Med Toxicol (2015) 1.00
Multi-center trial of baclofen for abstinence initiation in severe cocaine-dependent individuals. Drug Alcohol Depend (2009) 1.00
Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry (2009) 1.00
Validity of the distinction between primary and secondary substance use disorder in patients with bipolar disorder: data from the first 1000 STEP-BD participants. Am J Addict (2006) 1.00
Longer time to antipsychotic treatment discontinuation for any cause is associated with better functional outcomes for patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder. J Clin Psychiatry (2007) 1.00
Deep brain stimulation of the nucleus accumbens reduces alcohol intake in alcohol-preferring rats. Neurosurg Focus (2010) 0.99
Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials Network. J Subst Abuse Treat (2010) 0.99
Research design considerations for clinical studies of abuse-deterrent opioid analgesics: IMMPACT recommendations. Pain (2012) 0.99
Self-harm and suicidal behavior in women with comorbid PTSD and substance dependence. Am J Addict (2006) 0.98
Treatment utilization by women with PTSD and substance dependence. Am J Addict (2004) 0.98
Prescription opioid abuse: challenges and opportunities for payers. Am J Manag Care (2013) 0.97
Generalizability of clinical trials for cannabis dependence to community samples. Drug Alcohol Depend (2010) 0.97
Site selection in community-based clinical trials for substance use disorders: strategies for effective site selection. Am J Drug Alcohol Abuse (2011) 0.97
Depression precipitated by alcohol use in patients with co-occurring bipolar and substance use disorders. J Clin Psychiatry (2008) 0.96
The Michigan Alcoholism Screening Test and its shortened form: a meta-analytic inquiry into score reliability. Subst Use Misuse (2007) 0.95
Predictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. Drug Alcohol Depend (2009) 0.95
HIV risk behavior in treatment-seeking opioid-dependent youth: results from a NIDA clinical trials network multisite study. J Acquir Immune Defic Syndr (2010) 0.95
Adherence to pharmacotherapy in bipolar disorder patients with and without co-occurring substance use disorders. J Clin Psychiatry (2007) 0.94
Chronic pain severity in opioid-dependent patients. Am J Drug Alcohol Abuse (2008) 0.93
Training Latin American primary care physicians in the WPA module on depression: results of a multicenter trial. Psychol Med (2005) 0.93
Treatment of patients with substance use disorders, second edition. American Psychiatic Association. Am J Psychiatry (2006) 0.93
Craving of prescription opioids in patients with chronic pain: a longitudinal outcomes trial. J Pain (2012) 0.93
Rapid cognitive screening of patients with substance use disorders. Exp Clin Psychopharmacol (2009) 0.92
The history of community mental health treatment and rehabilitation for persons with severe mental illness. Community Ment Health J (2003) 0.92
The course of substance use disorders in patients with borderline personality disorder and Axis II comparison subjects: a 10-year follow-up study. Addiction (2010) 0.91
Treatment of substance use disorders in schizophrenia: a unifying neurobiological mechanism? Curr Psychiatry Rep (2005) 0.91
Positive affect and stress reactivity in alcohol-dependent outpatients. J Stud Alcohol Drugs (2013) 0.90
Benzodiazepine use during buprenorphine treatment for opioid dependence: clinical and safety outcomes. Drug Alcohol Depend (2013) 0.90
Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care. Psychiatry Res (2008) 0.90
Anxiety disorders among patients with co-occurring bipolar and substance use disorders. Drug Alcohol Depend (2005) 0.90
The relationship between educational attainment and relapse among alcohol-dependent men and women: a prospective study. Alcohol Clin Exp Res (2003) 0.90
Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Res (2002) 0.89
Bipolar disorder and alcohol use disorder: a review. Curr Psychiatry Rep (2012) 0.89